Barbara Romagnoli

USPTO Granted Patents = 21 (Patent Applications = 2)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 7.9

ph-index = 7

Forward Citations = 123(Granted Patents)

Location History:

St. Louis, FR (2010 - 2016)
Allschwil, CH (2014 - 2016)
Binningen, CH (2013 - 2022)

Company Filing History:

5. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11421001 - Template-fixed peptidomimetics (2022-08-23),

2. 10787486 - Template-fixed peptidomimetics (2020-09-29),

3. 10144765 - Template-fixed peptidomimetics (2018-12-04),

4. 10000535 - Template-fixed peptidomimetics (2018-06-19),

5. 9879047 - Template-fixed peptidomimetics (2018-01-30),

6. 9637520 - Template-fixed peptidomimetics with CXCR7 modulating activity (2017-05-02),

7. 9556234 - Template-fixed peptidomimetics (2017-01-31),

8. 9518092 - Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity (2016-12-13),

9. 9284352 - Beta-hairpin peptidomimetics having CXCR4 antagonizing activity (2016-03-15),

10. 9109009 - Template-fixed peptidomimetics with CXCR7 modulating activity (2015-08-18),

11. 9073973 - Dye conjugates of template-fixed peptidomimetics (2015-07-07),

12. 8921325 - Template-fixed peptidomimetics (2014-12-30),

13. 8895695 - Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity (2014-11-25),

14. 8883720 - Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity (2014-11-11),

15. 8865656 - Beta-hairpin peptidomimetics having CXCR4 antagonizing activity (2014-10-21),

Title: **Innovative Contributions of Barbara Romagnoli**

Introduction

Barbara Romagnoli, based in Binningen, Switzerland, is a distinguished inventor and researcher with a remarkable portfolio that includes 21 patents. Her innovative work, primarily in the field of biochemistry, showcases her commitment to advancing medical science through novel therapeutic approaches.

Latest Patents

One of Romagnoli's latest patents is centered around template-fixed peptidomimetics, specifically the structure Cyclo(-Tyr-His-X-Cys-Ser-Ala-Pro-Dab-Arg-Tyr-Cys-Tyr-Gln-Lys-Pro-Pro). This invention incorporates a disulfide bond between Cys4 and Cys11, along with pharmaceutically acceptable salts. These compounds, with X being either Ala or Tyr, exhibit antagonistic properties against the CXCR4 receptor. This innovative approach offers potential therapeutic applications in treating cancers related to CXCR4 receptor activity.

Career Highlights

Throughout her career, Barbara has made significant contributions while working at renowned organizations such as Polyphor Ltd. and the University of Zurich. Her tenure at these institutions has enabled her to drive forward her research and innovation efforts, making a substantial impact on the scientific community.

Collaborations

Barbara Romagnoli has collaborated with noteworthy colleagues, including Daniel Obrecht and Frank Gombert. These collaborations have facilitated the exchange of ideas and knowledge, enhancing the quality of research and the development of groundbreaking solutions in her field.

Conclusion

Barbara Romagnoli continues to be a trailblazer in her field, demonstrating how innovative thinking and collaborative efforts can lead to significant advancements in healthcare. Her contributions through her patents and collaborations firmly establish her as a key figure in the world of scientific innovation.

This text is generated by artificial intelligence and may not be accurate.